J.P. Morgan analyst Chris Schott maintained a Buy rating on Gilead Sciences (GILD – Research Report) today and set a price target of $115.00.

Richard Staines spoke with experts from Veeva and LEO Pharma to find out how far this technology can go as a sales tool. AI is proving to be hugely influential in our daily lives, with many ...

With this New Moon highlighting your partnerships, look at how you relate to others. Whether love or business, now is the moment to refresh your connections. Aquarius invites you to explore ...

Create the love that resonates with your soul, dearest Leo. You have always craved a love that was different than most. Yet, you haven’t always permitted yourself to go after this kind of ...

Natco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 20,532.26 Crore) operating in Pharmaceuticals sector. Natco Pharma Ltd. key Products/Revenue Segments ...

Rights Aug 02, 2023 Aug 02, 2023 Feb 08, 2023 Rights ratio: 5 share for every 46 held at a price of Rs 81.0 ...